535
edits
Changes
no edit summary
!Sample type
!LOD*** (H1N1)
TCID50/mL****
|-
|Abbott<ref name="Arti18">Abbott RIDT Product Information, Abbott, https://www.globalpointofcare.abbott/nl/product-details/binaxnow-influenza-a-and-b.html</ref>
|90-99%
|NPS, NS direct
|nN/aA
|-
|Becton Dickinson & Co.<ref name="Arti19">Becton Dickinson & Co. RIDT Product Information, Becton Dickinson & Co., https://www.bd.com/en-us/offerings/capabilities/microbiology-solutions/point-of-care-testing/veritor-system</ref>
|95-96%
|NS, NPS, NPA, NPW direct, NP, NPA, NPW in VTM
|nN/aA
|-
|Quidel Corp<ref name="Arti21">Quidel QuickVue RIDT Product Information, Quidel, https://www.quidel.com/sites/default/files/product/documents/EF1350313EN00_1.pdf</ref>
|QuickVue® Influenza A + B
|Yes
|N\/A
|81,5%
|97,8%
|99,4%
|NS, NPS direct, NPA(waived), NPW(not waived)
|N\/A
|-
|Remel/Thermo Fisher.<ref name="Arti23">XPECT™ RIDT Product Information, Remel/Thermo Fisher, https://www.thermofisher.com/document-connect/document-connect.html?url=https%3A%2F%2Fassets.thermofisher.com%2FTFS-Assets%2FMBD%2FInstructions%2FIFU24600%2520.pdf&title=WHBlY3QgRmx1IEEgYW5kIEI=</ref>
'''*'''PPA: positive percent agreement (True positive / total true positive)
'''**'''NNANPA: negative percent agreement (True negative / total true negative)
'''***'''LOD: Limit of detection
